Fulgent Genetics (FLGT) executive compensation, 2026 proxy

Ming Hsieh, Chief Executive Officer, was paid $6.2M in 2025, up 1% from $6.1M the year before. The CEO-to-median-employee pay ratio was 92:1, on median employee pay of $67,465.

Filed
March 31, 2026
Annual meeting
May 14, 2026
Pay year
2025
Named executives
4
CEO total pay
$6.2M+1% vs prior year
CEO to median employee
92:1median $67,465
CEO pay in equity
64%$4M in awards
CEO Salary
$1,000,000Unchanged from prior year
CEO Stock Awards
$4,000,000Grant date fair value
CEO Non-Equity Incentive
$1,207,000Based on company performance
Median Employee Pay
$67,465Estimated annual total
CEO Pay Ratio
92:1CEO to median employee

How Hsieh was paid

$6.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary16%Stock awards64%Non-equity incentive19%

Named executive officers

ExecutiveTotal
Ming HsiehChief Executive Officer$6,207,000
Paul KimChief Financial Officer$2,773,352
Hanlin GaoChief Scientific Officer and Laboratory Director$2,352,249
Jian XiePresident and Chief Operating Officer$2,807,658

What changed and why

  • $6.2MChief Executive Officer Ming Hsieh received total compensation of $6,207,000 for fiscal year 2025.
  • $4MStock awards granted to the Chief Executive Officer totaled $4,000,000 in the form of time-based and performance-based RSUs.
  • $1.2MNon-equity incentive plan compensation for the Chief Executive Officer was $1,207,000.
  • $67,465The median employee's annual total compensation was estimated to be $67,465.
  • The resulting ratio of the Chief Executive Officer's annual total compensation to the median employee pay was 92 to 1.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.